[Physiological and pharmacological aspects of fibrinolysis].
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D045930:Anabolic Agents / Q000494:pharmacology; D001162:Arteriosclerosis Obliterans / Q000097:blood; D001645:Biguanides / Q000494:pharmacology; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects; D002994:Clofibrate / Q000494:pharmacology; D003327:Coronary Disease / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood; D005032:Ethylestrenol / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D008687:Metformin / Q000494:pharmacology; D009203:Myocardial Infarction / Q000097:blood; D010629:Phenformin / Q000494:pharmacology; D013453:Sulfonylurea Compounds / Q000494:pharmacology; D013739:Testosterone / Q000494:pharmacology; D013927:Thrombosis / Q000097:blood
D000305:Adrenal Cortex Hormones; D045930:Anabolic Agents; D001645:Biguanides; D007328:Insulin; D013453:Sulfonylurea Compounds; D013739:Testosterone; D008687:Metformin; D005032:Ethylestrenol; D010629:Phenformin; D002994:Clofibrate
Aspetti fisiologici e farmacologici della firinolisi.